Back to Search
MEGAN SILL, DMD
DMD
Dentist
NPI: 1639664170Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
DentistPrimary
Dentist
Code: 122300000X
0401416444(VA)
Research & Publications (20)
Antibiotic susceptibility of invasive Haemophilus influenzae strains in Canada.
PMID 18227189·Antimicrob Agents Chemother·2008
8-other
Molecular characterization of four Haemophilus influenzae serotype a strains isolated from patients in Quebec, Canada.
PMID 18026212·Can J Microbiol·2007
8-other
Population genetics and antibiotic susceptibility of invasive Haemophilus influenzae in Manitoba, Canada, from 2000 to 2006.
PMID 17922774·FEMS Immunol Med Microbiol·2007
8-other
A phase II trial of erlotinib in recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
PMID 19574787·Int J Gynecol Cancer·2009
3-trial
Sexual risk-taking among adult dating couples in the United States.
PMID 19493216·Perspect Sex Reprod Health·2009
8-other
Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
PMID 19139430·J Clin Oncol·2009
3-trial
A phase II trial of paclitaxel poliglumex in recurrent or persistent ovarian or primary peritoneal cancer (EOC): a Gynecologic Oncology Group Study.
PMID 18829087·Gynecol Oncol·2008
3-trial
A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
PMID 18295319·Gynecol Oncol·2008
3-trial
Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: a phase I and feasibility trial of the Gynecologic Oncology Group.
PMID 18597837·Gynecol Oncol·2008
3-trial
Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study.
PMID 18612157·J Clin Oncol·2008
3-trial
Poly-k-trend tests for survival adjusted analysis of tumor rates formulated as approximate multiple contrast test.
PMID 18781526·J Biopharm Stat·2008
7-preclinical
Approximate simultaneous confidence intervals for multiple contrasts of binomial proportions.
PMID 18932137·Biom J·2008
7-preclinical
A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: a Gynecologic Oncology Group study.
PMID 17306350·Gynecol Oncol·2007
3-trial
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study.
PMID 18024863·J Clin Oncol·2007
3-trial
A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: a gynecologic oncology group study.
PMID 17597196·Gynecol Oncol·2007
3-trial
Characterization of invasive Haemophilus influenzae disease in Manitoba, Canada, 2000-2006: invasive disease due to non-type b strains.
PMID 17516405·Clin Infect Dis·2007
8-other
Nucleotide sequence diversity of the bexA gene in serotypeable Haemophilus influenzae strains recovered from invasive disease patients in Canada.
PMID 17460059·J Clin Microbiol·2007
8-other
Invasive Haemophilus influenzae in Manitoba, Canada, in the postvaccination era.
PMID 16597886·J Clin Microbiol·2006
8-other
Molecular epidemiology of urinary tract isolates of vancomycin-resistant Enterococcus faecium from North America.
PMID 16621463·Int J Antimicrob Agents·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 24565 Dulles Landing Dr Unit 190
Dulles, VA 20166 - Phone
- (703) 854-9942
Quick Facts
- NPI
- 1639664170
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile